성매개감염 진료지침 2023

## 임상질문 및 권고안

### 임균 감염, 임질 (Gonorrhea)

1. 최근 azithromycin의 내성균의 급속한 증가를 고려할 때, 단순 생식기 또는 직장 임균 치료제로 ceftriaxone과 azithromycin의 병합요법이 적절한가?

### References
1. Day et al. Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infectious Diseases (2022) 22:524.
2. St. Cyr et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. Weekly / December 18, 2020 / 69(50);1911-1916.
3. Barbee LA, Soge OO, Holmes KK, et al. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. J Antimicrob Chemother 2014; 69(6): 1572-1578. doi: 10.1093/jac/dkt540.
4. Pereira R, Cole MJ and Ison CA. Combination therapy for gonorrhoea: in vitro synergy testing. J Antimicrob Chemother 2013; 68(3): 640-643. doi: 10.1093/jac/dks449.
5. Wind CM, de Vries HJ and van Dam AP. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilu- tion. Int J Antimicrob Agents 2015; 45(3): 305-308. doi: 10.1016/j.ijantimicag.2014.10.020.
6. Furuya R, Nakayama H, Kanayama A, et al. In vitro synergistic effects of double combinations of beta- lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother 2006; 12(4): 172-176. doi: 10.1007/s10156-006-0445-z.
7. Singh V, Bala M, Bhargava A, et al. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. PLoS One 2018; 13(3): e0193678. doi: 10.1371/journal.pone.0193678.
8. Cole MJ, Spiteri G, Jacobsson S, et al. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. BMC Infect Dis 2017; 17(1): 617. doi: 10.1186/s12879-017-2707-z.
9. Yasuda M, Ito S, Hatazaki K, et al. Remarkable increase of Neisseria gonorrhoeae with decreased susceptibility of azithromycin and increase in the failure of azithromycin therapy in male gonococcal urethritis in Sendai in 2015. J Infect Chemother 2016; 22(12): 841-843. doi: 10.1016/j.jiac.2016.07.012.
10. Wi T, Lahra MM, Ndowa F, et al. Antimicrobial resis- tance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med 2017; 14(7): e1002344. doi: 10.1371/journal.pmed.1002344.

<PAGE>105